Chemical and biological studies on a series of novel (trans-(1R,2R)-, trans-(1S,2S)-, and cis-1,2-diaminocyclohexane)platinum(IV) carboxylate complexes

Journal of Medicinal Chemistry

Volumn 40, Issue 1, 1997, Pages 112-116

  Khokhar, Abdul R ^a   Al Baker, Salam ^a   Shamsuddin, Shaikh ^a   Siddik, Zahid H ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN DERIVATIVE; IPROPLATIN; PLATINUM 1,2 DIAMINOCYCLOHEXANE; PLATINUM 1,2 DIAMINOCYCLOHEXANE 2(ACETATE)METHYLMALONATE; TETRAPLATIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; COMPLEX FORMATION; CONTROLLED STUDY; DRUG SYNTHESIS; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKEMIA; LEUKEMIA L 1210; MALE; MOUSE; NONHUMAN; RETICULOSARCOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; CYCLOHEXYLAMINES; DRUG RESISTANCE, MULTIPLE; ISOMERISM; LEUKEMIA L1210; LEUKEMIA P388; MICE; ORGANOPLATINUM COMPOUNDS; TUMOR CELLS, CULTURED;

EID: 0031022861     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm960587l     Document Type: Article

References (41)

1. Carter, S. K. Cisplatin-Past, Present and Future. In Platinum Coordination Complexes in Cancer Chemotherapy; Hacker, M. P., Douple, E. B., Krakoff, I. H., Eds.; Martinus Nijhoff: Boston, 1984; pp 359-376.
2. Durant, J. R. Cisplatin: A Clinical Overview. In Cisplatin, Current Status and New Developments; Preatayko, A. W., Crooke, S. T., Karter, S. K., Eds.; Academic Press: New York, 1980; pp 317-321.
3. Loehrer, P. J.; Einhorn, L. H. Drugs Five Years Later, Cisplatin. Ann. Intern. Med. 1984, 100, 704-713.
4. Krakoff, I. H. Nephrotoxicity of Cis-dichlorodiammineplatinum-(II). Cancer Treat. Rep. 1979, 63. 1523.
5. Von Hoff, D. D.; Schilsky, R.; Reichert, C. M.; Reddick, R. L.; Rozencweig, M.; Young, R. C.; Muggia, F. M. Toxic Effect of Cis-dichlorodiammineplatinum(II) in Man. Cancer Treat. Rep. 1979, 63, 1527-1531.
6. Loehrer, P. J.; Williams, S. D.; Einhorn, L. H. Testicular Cancer: The Quest Continues. J. Natl. Cancer Inst. 1988, 80, 1373.
7. Eastman, A.; Schulte, N.; Sheibani, N.; Sorenson, C. M. Mechanism of Resistance to Platinum Drugs. In Platinum and Other Coordination Complexes in Cancer Chemotherapy; Nicolini, M., Ed.; Martinus Nijhoff: Boston, 1988; pp 178.
8. Harrap, K. R. Preclinical Studies Identifying Carboplatin as a Viable Cisplatin Alternative. Cancer Treat. Rev. 1985, 12, 21-33.
9. Mangioni, C.; Bolis, G.; Pecorelli, S.; Bragman, K.; Epis, A.; Favalli, G.; Gambino, A.; Landoni, F.; Presti, M.; Torri, W.; Vassena, L.; Zanaboni, F.; Marsoni, S. Randomised Trial in Advanced Ovarian Cancer Comparing Cisplatin and Carboplatin. J. Natl. Cancer Inst. 1989, 81, 1464-1471.
10. Burchenal, J. H.; Kalaher, K.; Dew, K. Studies of Crossresistance Synergistic Combinations and Blocking of Activity of Platinum Derivatives. Biochimie 1978, 60, 961-965.
11. Christian, M. C.; Kohn, E.; Sarosy, G.; Link, C.; Davis, P.; Adamo, D.; Weiss, R. B.; Brewster, L.; Lombardo, F.; Reed, E. Phase I and Pharmacologie Study of Ormaplatin (OP)/Tetraplatin. Proc. Am. Soc. Clin. Oncol. 1992, 11, 117 (abstract).
12. Extra, J. M.; Espie, M.; Calvo, F.; Ferme, C.; Mignot, L.; Marty, M. Phase I Study of Oxaliplatin in Patients with Advanced Cancer. Cancer Chemother. Pharmacol. 1990, 25, 299-303.
13. Perez-Soler, R.; Lopez-Berestein, G.; Lauthersztian, J.; Al-Baker, S.; Francis, K.; Macias-Kiger, D.; Raber, M. N.; Khokhar, A. R. Phase I Clinical and Pharmacological Study of Liposome-Entrapped cis-bis-Neodecanoato-trans-R,R-l,2-Diaminocyclohexaneplatinum(II). Cancer Res. 1990, 50, 4255-4259.
14. Pendyala, L.; Cowens, J. W.; Maclajewicz, S.; Creaven, P. S. Clinical Pharmacokinetics of cis-Dichloro-trans-Dihydroxy-bis-(Isopropylamine)Platinum(IV). In Platinum Coordination Complexes in Cancer Chemotherapy; Hacker, M. P., Douple. E. B., Krakoff, I. H., Eds.; Martinus Nijhoff: Boston, 1984; p 114.
15. Anderson, W. K.; Quagliato, D. A.; Haugwitz, R. D.; Narayanan, V. L.; Wolpert-DeFilippes, M. K. Synthesis, Physical Properties, and Antitumor Activity of Tetraplatin and Related Tetraplatinum(IV) Sterioisomers of 1,2-Diaminocyclohexane. Cancer Treat. Rep. 1986, 70, 997-1002.
16. Kelland, L. R.; Abel, G.; McKeage, M. J.; Jones, M.; Goddard, P. M.; Valenti, M.; Murrer, B. A.; Harrap. K, R. Preclinical Antitumor Evaluation of Bis-acetato-amine-dichloro-cyclohexylamine Platinum(IV): an Orally Active Platinum Drug. Cancer Res. 1993, 53, 2581-2586.
17. Kendall, D.; Alberts, D.; Peng, Y.-M. Activity of Tetraplatin Isomers Against Cisplatin Sensitive and Resistant Human Tumor Cell Lines. Proc. Am. Assoc. Cancer Res. 1989, 30, 469 (abstract).
18. (a) Boven, E.; Schluper, H. M. M.; Van Der Vijgh, W. J. F.; Pinedo, H. M. The Role of Human Ovarian Cancer Lines in the Selection of Clinically Active Platinum Compounds. Invest. New. Drugs 1987, 5, 59 (abstract).
19. (b) Boven, E.; Schluper, H. M. M.; Erkelens, C. A. M.; Luning, M.; Pinedo, H. M. A Nude Mouse-Phase II Model for Human Ovarian Cancer. Strahlenther. Oncol. 1989, 165, 534-535.
20. (a) Perez-Soler, R.; Khokhar, A. R.; Hacker, M. P.; Lopez-Berestein, G. Toxicity and Antitumor Activity of cis-bis-Cyclopentenecarboxylato-1,2-diaminocyclohexane Platinum(II) Encapsulated in Multilamellar Vesicles. Cancer Res. 1986, 46, 6269-6273.
21. (b) Khokhar, A. R.; Al-Baker, S; Brown, T.; Perez-Soler, R. Chemical and Biological Studies on a Series of Lipid Soluble (trans-(R,R)-and-(S,S)-1,2-Diaminocyclohexane) Platinum(II) Complexes Incorporated in Liposomes. J. Med. Chem. 1991, 34, 325-329.
22. (c) Khokhar, A. R.; Al-Baker, S.; Siddik, Z. H. Synthesis and Antitumor Activity of 1,2-Diaminoeyclohexaneplatinum(IV) Complexes. J. Inorg. Biochem. 1994, 54, 39-47.
23. (a) Khokhar, A. R.; Shamsuddin, S.; Xu, Q. Synthesis and X-ray Crystal Structure of cis-1,4-Diaminocyclohoexanetetrachloroplatinum(IV): A New Anatitumor Agent. Inorg. Chim. Acta. 1994, 219, 193-197.
24. (b) Shamsuddin, S.; Khokhar, A. R. Synthesis and Crystal Structure of a New Antitumor Agent: [Pt-(cis-1,4-Diaminocyclohexane) (1,1-Cyclobutanedicarboxylate)]. J. Coord. Chem. 1994, 33, 83-91.
25. (c) Shamsuddin, S.; Takahashi, I.; Siddik, Z. H.; Khokhar, A. R. Synthesis, Characterization, and Antitumor Activity of a Series of Novel Cisplatin Analogs with cis-1,4-Diaminocyclohexane as Non-Leaving amine group. J. Inorg. Biochem. 1996, 61, 291-301.
26. 2]. Indian J. Chem. 1970, 8, 193-194.
27. Khokhar, A. R.; Krakoff, I. H.; Hacker, M. P.; McCormack, J. J. The Synthesis and Antitumor Properties of a Series of Water Soluble Carboxylato-(1,2-Diaminocyclohexane)Platinum(II) Complexes. Inorg. Chim. Acta 1985, 108, 63-66.
28. (a) Deacon, G. B.; Phillips, R. J. Relationship Between the Carbon-Oxygen Stretching Frequencies of Carboxylato Complexes and the Type of Carboxylate Coordination. Coord. Chem. Rev. 1980, 33, 227.
29. (b) Khokhar, A. R.; Deng, Y. J.; Kido, Y.; Siddik, Z. H. Preparation, Characterization, and Antitumor Activity of New Ethylenediamineplatinum(IV) Complexes Containing Mixed Carboxylate Ligands. J. Inorg. Biochem. 1993, 50, 7987.
30. (c) Al-Baker, S.; Siddik, Z. H.; Khokhar, A. R. Synthesis and Characterization of New Antitumor trans-R,R,-, trans-S,S-and cis-1,2-Diaminocyclohexane Platinum(IV) Complexes. J. Coord. Chem. 1994, 31, 109-116.
31. Neidle, S.; Ismail, I. M.; Sadler, P. J. The Structure of the Antitumor Complex cis(Diamino)(1,1-Cyclobutanedicarboxylato)-Pt(II): X-Ray and NMR. J. Inorg. Biochem. 1980, 13, 205.
32. Burchenal, J. H.; Kalaher, K.; O'Toole, T.; Chisholm, J. Lack of Cross-Resistance Between Certain Platinum Coordination Compounds in Mouse Leukemia. Cancer Res. 1977, 37, 3455-3457.
33. Rose, W. C.; Schurig, J. E.; Huftalen, J. B.; Bradner, W. T. Antitumor Activity and Toxicity of Cisplatin Analogs. Cancer Treat. Rep. 1982, 66, 135-146.
34. Rose, W. C. Evaluation of Platinol Analogs Using the M5076 Murine Sarcoma. Anticancer Res. 1986, 6, 557-562.
35. Anderson, W. K.; Quagliato, D. A.; Haugwitz, R. D.; Narayanan, V. L.; Wolpert, D. Synthesis, Physical Properties, and Antitumor Activity of Tetraplatin and Related Tetrachloroplatinum(IV) Stereoisomers of 1,2-Diaminocyclohexane. Cancer Treat. Rep. 1986, 70, 997-1002.
36. Kidani, Y. Preparative Development of Antitumor 1,2-Cyclohexanediamine Platinum Complexes. Trends Inorg. Chem. 1991, 1, 107-125.
37. Chaney, S. G.; Wyrick, S.; Till, G. K. In Vitro Biotransformation of Tetrachloro(d,1-trans)-1,2-Diaminocyclohexaneplatinum(IV) (Tetraplatin) in Rat Plasma. Cancer Res. 1990, 50, 4539-4545.
38. Gibbons, G. R.; Wyrick, S.; Chaney, S. G. Rapid Reduction of Tetrachloro-(D,L-trans)-1,2-Diaminocyclohexaneplatinum (IV) (Tetraplatin) in RPMI 1640 Tissue Culture Medium. Cancer Res. 1989, 49, 1402-1407.
39. Geran, R. I.; Greenberg, N. H.; Macdonald, M. M.; Schumacher, A. M.; Abbott, B. J. Protocols for Screening Chemical Agents and Natural Products Against Animal Tumors and Other Biological Systems (3d ed.). Cancer Chemother. Rep. 3 (Part- 3) 1972, 1-103.
40. Prestayko, A. W.; Bradner, W. T.; Huftalen, J. B.; Rose, W. C.; Schurig, J. E.; Cleare, M. J.; Hydes, P. C.; Crooke, S. T. Antileukemic (L1210) Activity and Toxicity of cis-Dichlorodiammineplatinum(II) Analogs. Cancer Treat. Rep. 1979, 63, 1503-1508.
41. Begg, A. C. Principles and Practices of the Tumor Growth Delay Assay. In Rodent Tumor Models in Experimental Cancer Therapy; Kallman, R. F., Ed.; Pergamon Press: New York, 1987; p 114.